These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33005564)

  • 1. Evaluation of serum immunoglobulin (IgG, IgM, IgA) in potentially malignant disorders of oral cavity - A case control study.
    Tarsariya VM; Mehta DN; Raval N; Patadiya HH; Vachhrajani K; Ashem A
    J Oral Biol Craniofac Res; 2020; 10(4):665-669. PubMed ID: 33005564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of serum and salivary immunoglobulin G and immunoglobulin A in oral pre-cancer: A study in oral submucous fibrosis and oral lichen planus.
    Divya VC; Sathasivasubramanian S
    J Nat Sci Biol Med; 2014 Jan; 5(1):90-4. PubMed ID: 24678204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of serum immunoglobulin G and immunoglobulin A levels in oral submucous fibrosis patients.
    Swami AN; Kale LM; Choudhary SH; Singh AK; Aldhuwayhi SD; Thakare A
    Natl J Maxillofac Surg; 2022; 13(1):67-71. PubMed ID: 35911796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of depression, anxiety and serum cortisol in patients with oral lichen planus, leukoplakia and oral submucous fibrosis.
    A N; Khan Y; Sharma D; Sharma N; Mehta R; Gupta S
    Bioinformation; 2024; 20(6):655-659. PubMed ID: 39131520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Evaluation of Mitochondrial Antioxidants in Oral Potentially Malignant Disorders.
    Banerjee S; Mukherjee S; Mitra S; Singhal P
    Kurume Med J; 2020 Jul; 66(1):15-27. PubMed ID: 32378537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study.
    Rajanna VR; Raveendranath MC; Kathiresan S; Srinivasan S; Ilango J
    J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S382-S388. PubMed ID: 33149491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and Salivary IgA, IgG, and IgM Levels in Oral Lichen Planus: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Mozaffari HR; Zavattaro E; Abdolahnejad A; Lopez-Jornet P; Omidpanah N; Sharifi R; Sadeghi M; Shooriabi M; Safaei M
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30513983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Oral Submucous Fibrosis With Other Oral Potentially Malignant Disorders: A Clinical Retrospective Study.
    S S; R S
    Cureus; 2023 Nov; 15(11):e49642. PubMed ID: 38161840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber.
    Biocina-Lukenda D; Cekić-Arambasin A; Markeljević J; Buković D
    Coll Antropol; 2008 Mar; 32(1):161-3. PubMed ID: 18496909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of serum, salivary immunoglobulin G, immunoglobulin A levels and total protein, hemoglobin in smokeless tobacco chewers and oral submucous fibrosis patients.
    Balakrishnan C; Aswath N
    Contemp Clin Dent; 2015 Sep; 6(Suppl 1):S157-62. PubMed ID: 26604567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of major immunoglobulins in smokers and gutkha chewers.
    Prajapati KJ; Chawda JG
    J Oral Maxillofac Pathol; 2016; 20(2):219-23. PubMed ID: 27601812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of serum and salivary immunoglobulin G and A levels with total serum protein in oral submucous fibrosis patients: A case control study.
    Kandasamy M; Jaisanghar N; Austin RD; Srivastava KC; Anusuya GS; Anisa N
    J Pharm Bioallied Sci; 2016 Oct; 8(Suppl 1):S126-S132. PubMed ID: 27829763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum immunoglobulins IgA, IgG and IgM, and oral lichen planus].
    Albanidou-Farmaki E; Kayavis I; Sideropoulos I; Papanayiotou P; Polymenidis Z
    Stomatologia (Athenai); 1990; 47(2):114-20. PubMed ID: 2130546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
    Kaur J; Jacobs R
    J Korean Assoc Oral Maxillofac Surg; 2015 Aug; 41(4):171-5. PubMed ID: 26339574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and correlation of anxiety, depression and serum cortisol levels in patients with oral submucous fibrosis and leukoplakia: A clinicohematological study.
    Manshi P; Byatnal AR; Ramesh D; Deshpande A; Reddy VS; Najmuddin M
    J Oral Maxillofac Pathol; 2023; 27(1):54-59. PubMed ID: 37234308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary IgA and IgG in oral lichen planus and oral lichenoid reactions diseases.
    Ghaleyani P; Sardari F; Akbari M
    Adv Biomed Res; 2012; 1():73. PubMed ID: 23326803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
    Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
    J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of salivary and serum IgG, IgA levels with total protein in oral submucous fibrosis.
    Patidar KA; Parwani RN; Wanjari SP
    J Oral Sci; 2011 Mar; 53(1):97-102. PubMed ID: 21467820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulins and autoantibodies in patients with oral lichen planus.
    Lundström IM
    Int J Oral Surg; 1985 Jun; 14(3):259-68. PubMed ID: 3926670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.